The MMS works with the Massachusetts congressional delegation, national medical associations, and federal regulators to produce results for patients and physicians in Massachusetts and across the country.
Letter to House Committee on Ways and Means and Committee on Energy and Commerce Leadership in Opposition to I CAN Act
June 1, 2023
Letter in Support of Strengthening Medicare for Patients and Providers Act
April 19, 2023
Sign-on Letter to Cigna Regarding Modifier 25
April 18, 2023
AMA Sign-On Letter to Congressional Leadership Regarding Inflationary Update
March 15, 2023
Sign-on Letter to CMS Administrator Brooks-LaSure Regarding Proposed Prior Authorization Reforms
February 13, 2023
tMed Coalition Letter to Senators Markey and Warren Regarding Advancing Telehealth Beyond COVID-19 Act of 2022
November 2, 2022
Letter to Senator Markey Regarding Medicare Payment Cuts
October 24, 2022
Coalition Letter to Representatives Bera and Bucshon Regarding Supporting Medicare Providers Act of 2022
September 30, 2022
Thank You Letter to Massachusetts Congressional Delegation Regarding Inflation Reduction Act
September 6, 2022
Massachusetts Medical Society Comments to the U.S. Senate Committee on Finance in Response to the RFI on Mental and Behavioral Health
November 1, 2021
Letter to CMS Administrator Brooks-LaSure on Surprise Medical Billing Law Implementation, Part 2
September 2, 2021
Letter to CMS Administrator Brooks-LaSure on Surprise Medical Billing Law Implementation
June 24, 2021
Letter to Massachusetts Congressional Delegation on Telebehavioral Health Law (Section 123 Provision)
June 11, 2021
Letter to Congress Urging Extension of Moratorium on Medicare Sequester Cuts
February 12, 2021
Letter to Acting HHS Secretary on Practice Guidelines for Prescribing Buprenorphine
January 27, 2021
Letter to Department of Veterans Affairs on Scope of Practice Interim Final Rule
January 7, 2021
